These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15578948)

  • 21. RiboSubstrates: a web application addressing the cleavage specificities of ribozymes in designated genomes.
    Lucier JF; Bergeron LJ; Brière FP; Ouellette R; Elela SA; Perreault JP
    BMC Bioinformatics; 2006 Oct; 7():480. PubMed ID: 17076887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleic acid enzymes as a novel generation of anti-gene agents.
    Sioud M
    Curr Mol Med; 2001 Nov; 1(5):575-88. PubMed ID: 11899232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-based therapeutics and DNA delivery systems: a comprehensive review.
    Patil SD; Rhodes DG; Burgess DJ
    AAPS J; 2005 Apr; 7(1):E61-77. PubMed ID: 16146351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDV ribozymes.
    Been MD
    Curr Top Microbiol Immunol; 2006; 307():47-65. PubMed ID: 16903220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-cleaving ribozymes of hepatitis delta virus RNA.
    Been MD; Wickham GS
    Eur J Biochem; 1997 Aug; 247(3):741-53. PubMed ID: 9288893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribozymes: recent advances in the development of RNA tools.
    Puerta-Fernández E; Romero-López C; Barroso-delJesus A; Berzal-Herranz A
    FEMS Microbiol Rev; 2003 Apr; 27(1):75-97. PubMed ID: 12697343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Internal symmetry of the mirror type in the primary structure of ribozymes].
    Shpakov AO
    Tsitologiia; 2002; 44(6):561-9. PubMed ID: 12236100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.
    Weinberg MS; Ely A; Passman M; Mufamadi SM; Arbuthnot P
    Oligonucleotides; 2007; 17(1):104-12. PubMed ID: 17461767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribozymes as tools for therapeutic target validation in arthritis.
    Jarvis TC; Bouhana KS; Lesch ME; Brown SA; Parry TJ; Schrier DJ; Hunt SW; Pavco PA; Flory CM
    J Immunol; 2000 Jul; 165(1):493-8. PubMed ID: 10861088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribozymes, DNAzymes and small interfering RNAs as therapeutics.
    Sioud M; Iversen PO
    Curr Drug Targets; 2005 Sep; 6(6):647-53. PubMed ID: 16178798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribozymes: a modern tool in medicine.
    Khan AU; Lal SK
    J Biomed Sci; 2003; 10(5):457-67. PubMed ID: 12928586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribozymes: structure, characteristics and use as potential antiviral agents.
    Bartolomé J; Madejón A; Carreño V
    J Hepatol; 1995; 22(1 Suppl):57-64. PubMed ID: 7602079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of antigenomic hepatitis delta virus ribozyme cis- and trans- analogs.
    Savochkina L; Alekseenkova V; Belyanko T; Lukin M; Beabealashvilli R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):935-42. PubMed ID: 15560085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conformational switch controls hepatitis delta virus ribozyme catalysis.
    Ke A; Zhou K; Ding F; Cate JH; Doudna JA
    Nature; 2004 May; 429(6988):201-5. PubMed ID: 15141216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA hairpin loops repress protein synthesis more strongly than hammerhead ribozymes.
    Drew HR; Lewy D; Conaty J; Rand KN; Hendry P; Lockett T
    Eur J Biochem; 1999 Nov; 266(1):260-73. PubMed ID: 10542074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribozyme gene therapy: applications for molecular medicine.
    Lewin AS; Hauswirth WW
    Trends Mol Med; 2001 May; 7(5):221-8. PubMed ID: 11325634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group I intron ribozymes.
    Nielsen H
    Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-RNA chimeric hammerhead ribozyme to transforming growth factor-beta(1) mRNA inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats.
    Teng J; Fukuda N; Hu WY; Nakayama M; Kishioka H; Kanmatsuse K
    Cardiovasc Res; 2000 Oct; 48(1):138-47. PubMed ID: 11033116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.